New Users of Metformin Are at Low Risk of Incident Cancer
Diabetes Care2009Vol. 32(9), pp. 1620–1625
Citations Over TimeTop 1% of 2009 papers
Abstract
These results suggest that metformin use may be associated with a reduced risk of cancer. A randomized trial is needed to assess whether metformin is protective in a population at high risk for cancer.
Related Papers
- A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity(2007)
- → Metformin for Prevention of Type 2 Diabetes(2004)11 cited
- 당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과(2012)
- → [The relationship between hazard ratio and median survival time].(2019)
- → 059 Secondary progressive MS in the UK: a prospective cohort study(2022)